Professional societies have encouraged primary care providers to conduct spirometry testing for the detection of chronic obstructive pulmonary disease (COPD). In spite of this effort, the success rate is unacceptably low. Simple flow-sensing spirometers have technical flaws that can cause misreadings, and they are rarely checked for accuracy. When spirometry is performed by an experienced technologist, and when payment is made on the criterion of quality, the success rate for adults and school-aged children can be as high as 90%. But testing remains a challenge for younger children and the elderly. Regular feedback for the technologist about their testing results is essential. Even with an accurate spirometer, an able patient, and a skilled technologist, the ordering physician may wrongly interpret the data. Use of spirometry in primary care will continue to be problematic unless high quality testing is tied to reimbursement. Using FEV1 or peak flow measurements to rule out airway abnormality in the majority of patients, followed by referral for more sophisticated studies in those remaining, may be the best approach. Respiratory therapists should engage in this effort.
FergusonGT, EnrightPL, BuistAS, HigginsMW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program (NLHEP). Respir Care, 2000; 45(5):513–530. .
2.
FergusonGT, EnrightPL, BuistAS, HigginsMW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program (NLHEP). Chest, 2000; 117(4):1146–1161. .
3.
MacIntyreNR. The American Association for Respiratory Care and the National Lung Health Education Program: assuring quality in spirometry. Respir Care, 2004; 49(6):587–588. .
4.
FabbriLM, HurdSS; GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J, 2003; 22(1):1–2. .
5.
EnrightP. Spirometry for COPD is both underutilized and overutilized. Chest, 2007; 132(2):368–370. .
6.
PriceD, CrockettA, ArneM, GarbeB, JonesRC, KaplanA, et al. Spirometry in primary care case-identification, diagnosis and management of COPD. Prim Care Respir J, 2009; 18(3):216–223. .
7.
LeeTA, BartleB, WeissKB. Spirometry use in clinical practice following diagnosis of COPD. Chest, 2006; 129(6):1509–1515. .
8.
HanMK. Spirometry utilization for COPD: how do we measure up?. Chest, 2007; 132(2):403–409. .
9.
JooMJ, LeeTA, WeissKB. Geographic variation of spirometry use in newly diagnosed COPD. Chest, 2008; 134(1):38–45. .
10.
JohnsDP, BurtonD, WaltersJAE, Wood-BakerR. National survey of spirometer ownership and usage in general practice in Australia. Respirology, 2006; 11(3):292–298. .
11.
PoelsPJ, SchermerTR, JacobsA, AkkermansRP, HartmanJ, BottemaBJ, van WeelC. Variation in spirometry utilization between trained general practitioners in practices equipped with a spirometer. Scand J Prim Health Care, 2006; 24(2):81–87. .
12.
LevyML, QuanjerPH, BookerR, CooperBG, HolmesS, SmallI. Diagnostic spirometry in primary care: proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group (GPIAG) document. Prim Care Respir J, 2009; 18(3):130–147. .
13.
KaminskyDA, MarcyTW, BachandM, IrvinCG. Knowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians. Respir Care, 2005; 50(12):1639–1648. .
14.
NelsonSB, LaVangeLM, NieY, WalshJW, EnrightPL, MartinezFJ, et al. Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest, in press, 2011. .
WaltersJA. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD. Thorax, 2008; 63(5):408–414. .
17.
LusuardiM, De BenedettoF, PaggiaroP, SanguinettiCM, BrazzolaG, FerriP, DonnerCF. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from Spirometry in Asthma and COPD, a comparative evaluation Italian study. Chest, 2006; 129(4):844–852. .
18.
LeuppiJD, MiedingerD, ChhajedPN, BuessC, SchafrothS, BucherHC, TammM. Quality of spirometry in primary care for case finding of airway obstruction in smokers. Respiration, 2009; 79(6):469–474. .
19.
FrithP, CrockettA, BeilbyJ, MarshallD, AttewellR, RatnanesanA, GavagnaG. Simplified COPD screening: validation of the PiKo-6® in primary care. Prim Care Respir J, 2011; 20(2):190–198. .
20.
CastilloD, GuaytaR, GinerJ, BurgosF, CapdevilaC, SorianoJB, et al; FARMAEPOC Group. COPD case-finding by spirometry in high risk customers of urban community pharmacies: a pilot study. Respir Med, 2009; 103(6):839–845. .
21.
BoffinN, Van der StighelenV, PaulusD, Van RoyenP. Use of office spirometers in Flemish general practice: results of a telephone survey. Monaldi Arch Chest Dis, 2006; 65(3):128–132. .
22.
MillerMR, HankinsonJ, BrusascoV, BurgosF, CasaburiR, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J, 2005; 26(2):319–338. .
23.
SchermerTR, JacobsJE, ChavannesNH, HartmanJ, FolgeringHT, BottemaBJ, van WeelC. Validity of spirometric testing in a general practice population of patients with COPD. Thorax, 2003; 58(10):861–866. .
24.
TownsendMC, HankinsonJL, LindesmithLA, SlivkaWA, StiverG, AyresGT. Is my lung function really that good? Flow-type spirometer problems that elevate test results. Chest, 2004; 125(5):1902–1909. .
25.
LiistroG, VanweldeC, VinckenW, VandevoordeJ, VerledenG, BuffelsJ; COPD Advisory Board. Technical and functional assessment of 10 office spirometers: a multicenter comparative study. Chest, 2006; 130(3):657–665. .
26.
Pérez-PadillaR, Vázquez-GarcíaJC, MárquezMN, JardimJR, PertuzéJ, et al; Latin American COPD Prevalence Study (PLATINO) Team. The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care, 2006; 51(10):1167–1171. .
27.
SklootGS, EdwardsNT, EnrightPL. Four-year calibration stability of the EasyOne portable spirometer. Respir Care, 2010; 55(7):873–877. .
28.
CollenJ, GreenburgD, HolleyA, KingCS, HnatiukO. Discordance in spirometric interpretations using three commonly used reference equations vs NHANES III. Chest, 2008; 134(5):1009–1016. .
29.
PellegrinoR, ViegiG, BrusascoV, CrapoRO, BurgosF, CasaburiR, et al. Interpretative strategies for lung function tests. Eur Respir J, 2005; 26(5):948–968. .
30.
EnrightPL, SklootGS, Cox-GanserJM, UdasinIG, HerbertR. Quality of spirometry performed by 13,599 participants in the World Trade Center Worker and Volunteer Medical Screening Program. Respir Care, 2010; 55(3):303–309. .
31.
LoebJS, BlowerWC, FeldsteinJF, KochBA, MunlinAL, HardieWD. Acceptability and repeatability of spirometry in children using updated ATS/ERS criteria. Pediatr Pulmonol, 2008; 43(10):1020–1024. .
32.
BelliaV, SorinoC, CatalanoF, AugugliaroG, ScichiloneN, PistelliR, et al. Validation of FEV6 in the elderly: correlates of performance and repeatability. Thorax, 2008; 63(1):60–66. .
33.
EnrightPL. How to make sure your spirometry tests are of good quality. Respir Care, 2003; 48(8):773–776. .
34.
SwanneyMP, JensenRL, CrichtonDA, BeckertLE, CardnoLA, CrapoRO. FEV6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med, 2000; 162(3 Pt 1):917–919. .
35.
JingJY, HuangTC, CuiW, XuF, ShenHH. Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A meta-analysis. Chest, 2009; 135(4):991–998. .
36.
MalmstromK, PeszekI, BottoA, LuS, EnrightPL, ReissTF. Quality assurance of asthma clinical trials. Control Clin Trials, 2002; 23(2):143–156. .
37.
EnrightP, VollmerWM, LamprechtB, JensenR, JithooA, TanW, et al. Quality of spirometry tests performed by 9893 adults in 14 countries: the BOLD Study. Respir Med, 2011; 105(10):1507–1515. .
38.
HnatiukO, MooresL, LoughneyT, TorringtonK. Evaluation of internists' spirometric interpretations. J Gen Intern Med, 1996; 11(4):204–208. .
39.
DalesRE, VandemheenKL, ClinchJ, AaronSD. Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. Chest, 2005; 128(4):2443–2447. .
40.
ChavannesN, SchermerT, AkkermansR, JacobsJE, van de GraafG, BollenR, et al. Impact of spirometry on GPs' diagnostic differentiation and decision-making. Respir Med, 2004; 98(11):1124–1130. .
41.
PoelsPJ, SchermerTR, SchellekensDP, AkkermansRP, JacobsA, van den Bogart-JansenM, et al. General practitioners' needs for ongoing support for the interpretation of spirometry tests. Eur J Gen Pract, 2007; 13(1):16–19. .
42.
PoelsPJ, SchermerTR, SchellekensDP, AkkermansRP, de Vries RobbéPF, KaplanA, et al. Impact of a spirometry expert system on general practitioners' decision-making. Eur Respir J, 2008; 31(1):84–92. .
43.
MillerMR, QuanjerPH, SwanneyMP, RuppelG, EnrightPL. Interpreting lung function data using 80% of predicted and fixed thresholds misclassifies over 20% of patients. Chest, 2011; 139(1):57–59. .
44.
Pérez-PadillaR, HallilPC, Vázquez-GarcíaJC, MuiñoA, MáquezM, LópezMV, et al; PLATINO Group. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD, 2007; 4(2):113–120. .
45.
VandevoordeJ, VerbanckS, SchuermansD, BroekaertL, DevroeyD, KartounianJ, VinckenW. Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity. Eur Respir J, 2008; 31(2):391–395. .
46.
LeoneN, CourbonD, ThomasF, BeanK, JégoB, LeynaertB, et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med, 2009; 179(6):509–516. .
47.
GuerraS, SherrillDL, VenkerC, CeccatoCM, HalonenM, MartinezFD. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax, 2010; 65(6):499–504. .
48.
IyerVN, SchroederDR, ParkerKO, HyattRE, ScanlonPD. The nonspecific pulmonary function test: longitudinal follow-up and outcomes. Chest, 2011; 139(4):878–886. .
49.
PratterMR, AbouzgheibW, AkersS, KassJ, BartterT. An algorithmic approach to chronic dyspnea. Respir Med, 2011; 105(7):1014–1021. .
ParkesG, GreenhalghT, GriffinM, DentR. Effect on smoking quit rate telling patients their lung age: the Step2quit randomized controlled trial. BMJ, 2008; 336(7644):598–600. .
54.
LinK, WatkinsB, JohnsonT, RodriguezJA, BartonMB; US Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the US. Preventive Services Task Force. Ann Intern Med, 2008; 148(7):535–543. .
55.
LipkusIM, ProkhorovAV. The effects of providing lung age and respiratory symptoms feedback on community college smokers' perceived smoking-related health risks, worries and desire to quit. Addict Behav, 2007; 32(3):516–532. .
56.
QuanjerPH, EnrightP. Should we use ‘lung age'?. Prim Care Respir J, 2010; 19(3):197–199. .
57.
BizeR, BurnandB, MuellerY, CornuzJ. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev, 2005;(4):CD004705. .
58.
WiltTJ, NiewoehnerD, KaneRL, MacDonaldR, JosephAM. Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res, 2007; 9(1):21–32. .
59.
EnrightP. Provide GPs with spirometry, not spirometers. Thorax, 2008; 63(5):387–388. .
60.
Pérez-PadillaR, VollmerWM, Vázquez-GarcíaJC, EnrightPL, MenezesAM, BuistAS; BOLD and PLATINO Study Groups. Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease?. Int J Tuberc Lung Dis, 2009; 13(3):387–393. .
61.
EnrightP. Over 90% of smokers don't need an expensive inhaler. Prove it by using a pocket spirometer. ERS Buyers Guide to Respiratory Care Products 2010. http://www.ersbuyersguide.org/index.php?Itemid=101. Accessed November 2, 2011..
62.
American Association for Respiratory Care. Apply for the office spirometry certificate (OSC). https://secure.aarc.org/osc/training.cfm. Accessed November 2, 2011..
63.
Pérez-PadillaR, Vázquez-GarcíaJC, MárquezMN, JardimJR, PertuzéJ, LisboaC, et al; the Latin American COPD Prevalence Study (PLATINO) Team. The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care, 2006; 51(10):1167–1171. .
64.
BuistAS, McBurnieMA, VollmerWM, GillespieS, BurneyP, ManninoDM, et al; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet, 2007; 370(9589):741–750. .
65.
MillerMR, HankinsonJ, BrusascoV, BurgosF, CasaburiR, CoatesA, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J, 2005; 26(2):319–338. .
66.
ParkesG, GreenhalghT, GriffinM, DentR. Effect on smoking quit rate of telling patients their lung age: the Step2Quit randomised controlled trial. BMJ, 2008; 336(7644):598–600. .
67.
KaminskyDA, MarcyT, DorwaldtA, PinckneyR, DesarnoM, SolomonL, HughesJR. Motivating smokers in the hospital pulmonary function laboratory to quit smoking by use of the lung age concept. Nicotine Tob Res, 2011May6 [Epub ahead of print]. .
68.
QaseemA, WiltTJ, WeinbergerSE, HananiaNA, CrinerG, van der MolenT, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med, 2011; 155(3):179–191. .
69.
United States Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute. Survey: awareness of COPD—the nation's fourth leading cause of death—is rising, but understanding is still low. Smokers and those at risk are far less likely to talk to their doctor about symptoms. NIH News; November 9, 2009. http://www.nih.gov/news/health/nov2009/nhlbi-02.htm. Accessed September 28, 2011. .
70.
PatelMC, MehtaKB, MillerA. Peak flow in COPD: to define the relationship between FEV1 and PF in patients with COPD and compare it with that seen in asthma patients. Chest, 1999; 118(Suppl):200S. .
71.
MillerMR, HankinsonJ, BrusascoV, BurgosF, CasaburiR, CoatesA, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J, 2005; 26(2):319–338. .
72.
UngarWJ, CoytePC. Health services utilization reporting in respiratory patients. Pharmacy Medication Monitoring Advisory Board. J Clin Epidemiol, 1998; 51(12):1335–1342. .
